{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:28:18Z","timestamp":1740166098979,"version":"3.37.3"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T00:00:00Z","timestamp":1710720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T00:00:00Z","timestamp":1710720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s13760-024-02528-7","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T07:01:57Z","timestamp":1710745317000},"page":"1447-1449","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bickerstaff brain stem encephalitis preceding recurrent myelin oligodendrocyte glycoprotein antibody-associated disease"],"prefix":"10.1007","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-5578-5247","authenticated-orcid":false,"given":"John","family":"Ciarletta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca","family":"Weinstock-Guttman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangharsha","family":"Thapa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omid","family":"Mirmosayyeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samreen","family":"Awan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svetlana","family":"Eckert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,18]]},"reference":[{"key":"2528_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.885218","author":"E Sechi","year":"2022","unstructured":"Sechi E, Cacciaguerra L, Chen JJ, Mariotto S, Fadda G, Dinoto A et al (2022) Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and MRI features, diagnosis, and management. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2022.885218","journal-title":"Front Neurol"},{"key":"2528_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-325121","author":"SA Banks","year":"2020","unstructured":"Banks SA, Morris PP, Chen JJ, Pittock SJ, Sechi E, Kunchok A, Tillema JM, Fryer JP, Weinshenker BG, Krecke KN, Lopez-Chiriboga AS, Nguyen A, Greenwood TM, Lucchinetti CF, Zalewski NL, Messina SA, Flanagan EP (2020) Brainstem and cerebellar involvement in MOG-IgG-associated disorder versus aquaporin-4-IgG and MS. J Neurol Neurosurg Psychiatry. https:\/\/doi.org\/10.1136\/jnnp-2020-325121","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"2528_CR3","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1093\/brain\/awg233","volume":"126","author":"M Odaka","year":"2003","unstructured":"Odaka M, Yuki N, Yamada M, Koga M, Takemi T, Hirata K et al (2003) Bickerstaff\u2019s brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain-Barr\u00e9 syndrome. Brain 126(10):2279\u20132290","journal-title":"Brain"},{"issue":"8","key":"2528_CR4","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1177\/1352458520951046","volume":"27","author":"A Kunchok","year":"2021","unstructured":"Kunchok A, Flanagan EP, Krecke KN, Chen JJ, Caceres JA, Dominick J, Ferguson I, Kinkel R, Probasco JC, Ruvalcaba M, Santoro JD, Sieloff K, Timothy J, Weinshenker BG, McKeon A, Pittock SJ (2021) MOG-IgG1 and co-existence of neuronal autoantibodies. Mult Scler 27(8):1175\u20131186. https:\/\/doi.org\/10.1177\/1352458520951046","journal-title":"Mult Scler"},{"key":"2528_CR5","doi-asserted-by":"publisher","first-page":"832084","DOI":"10.3389\/fimmu.2022.832084","volume":"13","author":"J Guo","year":"2022","unstructured":"Guo J, Bu Y, Liu W (2022) Case report: a case with MOGAD and anti-NMDAR encephalitis overlapping syndrome mimicing radiological characteristics of CLIPPERS. Front Immunol 13:832084","journal-title":"Front Immunol"},{"issue":"3","key":"2528_CR6","doi-asserted-by":"publisher","first-page":"82","DOI":"10.31083\/j.jin2103082","volume":"21","author":"M Wang","year":"2022","unstructured":"Wang M, Tan J, Zhou Z, Wang Y, Bako SY, Yang Y et al (2022) Relapsing MOG-IgG-associated diseases coexisting with anti-NMDAR encephalitis: a case report and literature review. J Integr Neurosci 21(3):82","journal-title":"J Integr Neurosci"},{"key":"2528_CR7","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1007\/s00415-020-09869-2","volume":"267","author":"J Ding","year":"2020","unstructured":"Ding J, Ren K, Wu J, Li H, Sun T, Yan Y et al (2020) Overlapping syndrome of MOG-IgG-associated disease and autoimmune GFAP astrocytopathy. J Neurol 267:2589\u20132593","journal-title":"J Neurol"},{"key":"2528_CR8","doi-asserted-by":"publisher","first-page":"175628642096946","DOI":"10.1177\/1756286420969462","volume":"13","author":"P Liu","year":"2020","unstructured":"Liu P, Bai M, Yan X, Ren K, Ding J, Zhao D et al (2020) Possible coexistence of MOG-IgG-associated disease and anti-Caspr2 antibody-associated autoimmune encephalitis: a first case report. Ther Adv Neurol Disord 13:1756286420969462","journal-title":"Ther Adv Neurol Disord"},{"issue":"3","key":"2528_CR9","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","volume":"22","author":"B Banwell","year":"2023","unstructured":"Banwell B, Bennett JL, Marignier R, Kim HJ, Brilot F, Flanagan EP, Ramanathan S, Waters P, Tenembaum S, Graves JS, Chitnis T, Brandt AU, Hemingway C, Neuteboom R, Pandit L, Reindl M, Saiz A, Sato DK, Rostasy K, Paul F, Pittock SJ, Fujihara K, Palace J (2023) Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD panel proposed criteria. Lancet Neurol 22(3):268\u2013282","journal-title":"Lancet Neurol"},{"issue":"11","key":"2528_CR10","doi-asserted-by":"publisher","first-page":"585471","DOI":"10.3389\/fneur.2020.585471","volume":"12","author":"C Qin","year":"2020","unstructured":"Qin C, Tao R, Zhang SQ, Chen B, Chen M, Yu HH, Chu YH, Shang K, Wu LJ, Bu BT, Tian DS (2020) Predictive factors of resistance to high-dose steroids therapy in acute attacks of neuromyelitis optica spectrum disorder. Front Neurol 12(11):585471","journal-title":"Front Neurol"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-024-02528-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-024-02528-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-024-02528-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T02:44:09Z","timestamp":1721789049000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-024-02528-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,18]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["2528"],"URL":"https:\/\/doi.org\/10.1007\/s13760-024-02528-7","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"type":"print","value":"0300-9009"},{"type":"electronic","value":"2240-2993"}],"subject":[],"published":{"date-parts":[[2024,3,18]]},"assertion":[{"value":"12 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Svetlana Eckert has received compensation for speaking engagements from EMD Serono and has served on an advisory board for Genentech. Dr. Bianca Weinstock-Guttman received honoraria for serving in advisory boards and educational programs from Biogen Idec, Novartis, Genentech, Genzyme and Sanofi, Janssen, Abbvie and Bayer. She also received support for research activities from the National Institutes of Health, National Multiple Sclerosis Society, Department of Defense, and Biogen Idec, Novartis, Genentech, Genzyme and Sanofi. The authors report no conflicts of interest or further declarations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This report has been approved by the appropriate ethics committee and has therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the case report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}